# Safety of Yttrium-90 Ibritumomab Tiuxetan Radioimmunotherapy for Relapsed Low-Grade, Follicular, or Transformed Non-Hodgkin’s Lymphoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/safety-of-yttrium-90-ibritumomab-tiuxetan-radioimmunotherapy-for-relapsed-low/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Thomas E. Witzig,Christine A. White,Leo I. Gordon,Gregory A. Wiseman,Christos Emmanouilides,James L. Murray,John Lister,Pratik S. Multani |
| Citations | 291 |
| DOI | 10.1200/jco.2003.08.043 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2147581636 |
| PMID | 12663713 |
| Type | article |
| Year | 2003 |

## Paper authors

- [John Lister](https://scholariq.org/researchers/john-lister/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)

## Paper topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Radiopharmaceutical Chemistry and Applications](https://scholariq.org/topics/radiopharmaceutical-chemistry-and-applications/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.